B Cell Engineering Service for Immunotherapy

Creative Biolabs has built a perfect engineered B cell medicines platform to provide transformative therapies for your different disease researches, opening a new and paradigm-shifting class of cell therapy.

B Cell in Immune Cell Therapy

Except for antibody production, the B cells are involved in a wide array of functions of the immune response. Such as inflammation, antigen presentation, memory formation, and cytokine secretion.

Immune effector function of B cell:

  • Secreting large quantities of highly specific antibodies
  • Sustaining effector T cell and T follicular helper responses
  • Production of inflammatory or immune suppressive cytokines

Our B Cell Engineering Services for Immunotherapy

  • One-Stop Solution for B Cell Engineering

Creative Biolabs provides One-Stop Solution for B Cell Engineering, which includes a comprehensive range of site and technology services to support scientific research in immunotherapy. You can find any needed service for your project.

One-stop solution for B cell engineering.Fig.1 One-stop solution for B cell engineering. (Creative Biolabs)

By precision genome engineering technology to insert a gene into an exact chromosomal location. Creative Biolabs creates many B cell candidates for multiple diseases by swapping in different genes of interest. Then, the engineered B cells are expanded and differentiated into plasma cells that secrete the desired therapeutic antibody or protein by changing culture conditions.

  • B Cell Engineering Services for Immunotherapy

B cells can generate proteins and play key roles in humoral immunity. B cells can differentiate into different plasma cells, which secrete antibodies. B cells also secrete cytokines that can affect T-cell function, dendritic cell (DC) function, and lymphoid tissue reorganization.

Types of B cell engineering for immunotherapy.Fig.2 Types of B cell engineering for immunotherapy. (Creative Biolabs)

B Cell Engineering Service for Therapeutic Antibody Delivery

B Cell Engineering Service for Therapeutic Protein Delivery

Engineering B Cells with Enhanced IMMUNO-Regulatory Properties

B Cell Engineering Service for Therapeutic Antibody Delivery B Cell Engineering Service for Therapeutic Protein Delivery Engineering B Cells with Enhanced IMMUNO-Regulatory Properties
Creative Biolabs provides proprietary B cell engineering services for therapeutic antibody delivery which can act as membrane-bound surface receptors known as B cell receptors or are secreted as proteins that contribute to immunity in different ways. Creative Biolabs provides B cell engineering services to manufacture proteins to help your immune research. We could engineer B cells to produce any therapeutic protein you needed. We have developed a unique method for gene delivery to primary human B cells, which is an important technology to build a cell therapy for protein delivery. Creative Biolabs provides B cell engineering services to regulate the secretion of costimulatory immune cell ligands and immuno-regulatory molecules. We could engineer B cells and change the immuno-regulatory properties to meet your immunology research needs.
Learn More Learn More Learn More

Features & Benefits

  • Antibody-secreting B cells can produce protein indefinitely.
  • Antibody-secreting B cells produce similar quantities of protein as common cell lines.
  • B cell-based immunotherapy provides an alternative and promising strategy to specifically target tumor cells.

Professional consultation provides guidance before, during and after the B cell engineering project, please contact us for your tailored solution.

Frequently Asked Questions

Q1. What are the applications of engineered B cells?

Application Description
Antibody production Protection from pathogens
Antigen presentation T cell activation; T cell memory
Co-stimulation T cell activation; T cell memory
Tertiary lymphoid organ formation In-situ immune response
Cytokine-mediated stimulation T cell cytokines; T cell memory
Cytokine-mediated inhibition Reduced T cell activation Increased Tregs; Decreased inflammatory cytokines
Reference
  1. Gupta, S.L.; et al. B-cell-based immunotherapy: a promising new alternative. Vaccines (Basel). 2022, 10(6): 879.

Related Sections: